Cargando…

Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus

BACKGROUND: Chikungunya (CHIKV) virus is an important mosquito-borne virus causing outbreaks of acute febrile illness with arthropathy. The detection of specific antibodies against CHIKV is used for diagnosis after the acute viremic phase of the disease. However, a major challenge for serologic diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Fumagalli, Marcílio Jorge, de Souza, William Marciel, Espósito, Danillo Lucas Alves, Silva, Angélica, Romeiro, Marilia Farignoli, Martinez, Edson Zangiacomi, da Fonseca, Benedito Antônio Lopes, Figueiredo, Luiz Tadeu Moraes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056935/
https://www.ncbi.nlm.nih.gov/pubmed/30041676
http://dx.doi.org/10.1186/s12985-018-1028-1
_version_ 1783341420426297344
author Fumagalli, Marcílio Jorge
de Souza, William Marciel
Espósito, Danillo Lucas Alves
Silva, Angélica
Romeiro, Marilia Farignoli
Martinez, Edson Zangiacomi
da Fonseca, Benedito Antônio Lopes
Figueiredo, Luiz Tadeu Moraes
author_facet Fumagalli, Marcílio Jorge
de Souza, William Marciel
Espósito, Danillo Lucas Alves
Silva, Angélica
Romeiro, Marilia Farignoli
Martinez, Edson Zangiacomi
da Fonseca, Benedito Antônio Lopes
Figueiredo, Luiz Tadeu Moraes
author_sort Fumagalli, Marcílio Jorge
collection PubMed
description BACKGROUND: Chikungunya (CHIKV) virus is an important mosquito-borne virus causing outbreaks of acute febrile illness with arthropathy. The detection of specific antibodies against CHIKV is used for diagnosis after the acute viremic phase of the disease. However, a major challenge for serologic diagnosis of CHIKV and other alphaviruses is the cross-reactivity of antibodies to common antigens among these viruses. In the present study, we have developed an enzyme-linked immunosorbend assay using a recombinant envelope protein 2 of CHIKV produced in Escherichia coli system, as a capture antigen. RESULTS: High titers (1600 to 12,800) of anti-CHIKV antibodies were detected in human sera analyzed by the CHIKV assay, suggesting it may detect low levels of the antibodies presence. On the other side, cross-reactivity was not observed in mouse hyperimmune sera to Mayaro virus and other alphaviruses analyzed by the CHIKV immunosorbend assay, suggesting it is a CHIKV-specific test. Fifty-nine human serum samples of CHIKV infection suspected cases were tested for immunoglobulin G (IgG) and M (IgM) antibodies detection using the CHIKV immunosorbend assay. A total of 44% (26/59) of samples were positive for IgG to CHIKV, determining 89.66% sensitivity and 100% specificity when the assay is compared to a CHIKV-specific neutralization assay. In addition, 40.6% (24/59) of samples were positive for IgM, determining 92.48% sensitivity and 79.04% specificity by a Bayesian method in the absence of a gold standard. Moreover, CHIKV immunosorbend assay showed similar sensibilities to a commercial immunochromatography assay (Lumiquick, USA) for CHIKV IgG and IgM detection. CONCLUSION: In short, we have developed a rapid, simple, specific and sensitive CHIKV immunosorbend assay for IgG and IgM detection and our results showed potential applicability on the diagnosis of infections by this virus. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12985-018-1028-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6056935
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60569352018-07-30 Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus Fumagalli, Marcílio Jorge de Souza, William Marciel Espósito, Danillo Lucas Alves Silva, Angélica Romeiro, Marilia Farignoli Martinez, Edson Zangiacomi da Fonseca, Benedito Antônio Lopes Figueiredo, Luiz Tadeu Moraes Virol J Methodology BACKGROUND: Chikungunya (CHIKV) virus is an important mosquito-borne virus causing outbreaks of acute febrile illness with arthropathy. The detection of specific antibodies against CHIKV is used for diagnosis after the acute viremic phase of the disease. However, a major challenge for serologic diagnosis of CHIKV and other alphaviruses is the cross-reactivity of antibodies to common antigens among these viruses. In the present study, we have developed an enzyme-linked immunosorbend assay using a recombinant envelope protein 2 of CHIKV produced in Escherichia coli system, as a capture antigen. RESULTS: High titers (1600 to 12,800) of anti-CHIKV antibodies were detected in human sera analyzed by the CHIKV assay, suggesting it may detect low levels of the antibodies presence. On the other side, cross-reactivity was not observed in mouse hyperimmune sera to Mayaro virus and other alphaviruses analyzed by the CHIKV immunosorbend assay, suggesting it is a CHIKV-specific test. Fifty-nine human serum samples of CHIKV infection suspected cases were tested for immunoglobulin G (IgG) and M (IgM) antibodies detection using the CHIKV immunosorbend assay. A total of 44% (26/59) of samples were positive for IgG to CHIKV, determining 89.66% sensitivity and 100% specificity when the assay is compared to a CHIKV-specific neutralization assay. In addition, 40.6% (24/59) of samples were positive for IgM, determining 92.48% sensitivity and 79.04% specificity by a Bayesian method in the absence of a gold standard. Moreover, CHIKV immunosorbend assay showed similar sensibilities to a commercial immunochromatography assay (Lumiquick, USA) for CHIKV IgG and IgM detection. CONCLUSION: In short, we have developed a rapid, simple, specific and sensitive CHIKV immunosorbend assay for IgG and IgM detection and our results showed potential applicability on the diagnosis of infections by this virus. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12985-018-1028-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-07-24 /pmc/articles/PMC6056935/ /pubmed/30041676 http://dx.doi.org/10.1186/s12985-018-1028-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology
Fumagalli, Marcílio Jorge
de Souza, William Marciel
Espósito, Danillo Lucas Alves
Silva, Angélica
Romeiro, Marilia Farignoli
Martinez, Edson Zangiacomi
da Fonseca, Benedito Antônio Lopes
Figueiredo, Luiz Tadeu Moraes
Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus
title Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus
title_full Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus
title_fullStr Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus
title_full_unstemmed Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus
title_short Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus
title_sort enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of chikungunya virus
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056935/
https://www.ncbi.nlm.nih.gov/pubmed/30041676
http://dx.doi.org/10.1186/s12985-018-1028-1
work_keys_str_mv AT fumagallimarciliojorge enzymelinkedimmunosorbentassayusingrecombinantenvelopeprotein2antigenfordiagnosisofchikungunyavirus
AT desouzawilliammarciel enzymelinkedimmunosorbentassayusingrecombinantenvelopeprotein2antigenfordiagnosisofchikungunyavirus
AT espositodanillolucasalves enzymelinkedimmunosorbentassayusingrecombinantenvelopeprotein2antigenfordiagnosisofchikungunyavirus
AT silvaangelica enzymelinkedimmunosorbentassayusingrecombinantenvelopeprotein2antigenfordiagnosisofchikungunyavirus
AT romeiromariliafarignoli enzymelinkedimmunosorbentassayusingrecombinantenvelopeprotein2antigenfordiagnosisofchikungunyavirus
AT martinezedsonzangiacomi enzymelinkedimmunosorbentassayusingrecombinantenvelopeprotein2antigenfordiagnosisofchikungunyavirus
AT dafonsecabeneditoantoniolopes enzymelinkedimmunosorbentassayusingrecombinantenvelopeprotein2antigenfordiagnosisofchikungunyavirus
AT figueiredoluiztadeumoraes enzymelinkedimmunosorbentassayusingrecombinantenvelopeprotein2antigenfordiagnosisofchikungunyavirus